HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
James Hinrichs Appointed to Board of Directors and Chairman of the Audit Committee of Outset Medical
In addition to his board service, James Hinrichs will serve as Chair of the company's Audit Committee.
Monteris Medical Founders to Receive Pioneer in Technology Award
Founders Mark G. Torchia and Richard Tyc, are the 2020 recipients of the Pioneer in Technology Award by The Society for Brain Mapping & Therapeutics (SBMT).
Daniel Florin Joins Pulmonix Board of Directors
Daniel Florin has been serving as Executive Vice President at Zimmer Biomet Holdings Inc. since July 2019.
Abond CRO Announces Hiring Charley Bratton as Senior VP Corporate Marketing and Sales
Charley Bratton will lead an array of activities contributing to the company’s plans for accelerated growth and expansion of service offerings.
EarlySense Names John Dragovits as New SVP of Strategic Partnerships
John Dragovits has more than 30 years of experience as a healthcare and healthcare IT executive leader..
Dr Edward Evantash Appointed CMO of Alydia Health
Dr Edward Evantash joins Alydia from Hologic, a global leader in women’s healthcare technology.
Kenny Gardner Named Chief People Officer at DaVita Kidney Care
Kenny Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.
Edward C. Jauch, M.D. Appointed Chairman of Ischemia Care Clinical Advisory Board
The Ischemia Care clinical advisory board will guide Ischemia Care’s mission to empower clinicians with biological insights that minimize unnecessary invasive testing and raise diagnostic certainty for maximum treatment benefit.
Philippe Menu, MD-PhD, MBA Appointed CMO at SOPHiA GENETICS
Dr. Philippe Menu spent the last 8 years at McKinsey & Company where he co-led the McKinsey Cancer Center & served dozens of clients in the biopharma sector.
